人类对抗癌药物的研究,又向前迈进了一大步。加拿大多伦多玛嘉烈公主医院金宝家族乳腺癌研究所主任麦德华博士和美国加州大学洛杉矶分校丹尼斯·史拉蒙博士共同宣布,一种能有效抑制人类乳腺癌、卵巢癌、结肠癌、胶质母细胞瘤、肺癌、黑色素瘤、胰脏癌、前列腺癌等8种癌症,并令肿瘤发生显著萎缩的新型特效靶向药初步研究成功。据加拿大电视台报道,这种特效药的名字为CFI-400945,其研制时间长达10年。传统的癌症治疗方式主要为放化疗,直接攻击并杀灭癌细胞,其副作用是同时杀死健康细胞,对患者身体产生消极影响,且随着放化疗效果减弱,癌细胞重 Human anti-cancer drug research, another big step forward. Dr. Richard McEwan, director of the Campbell Family Breast Cancer Research Institute at Princess Margaret Hospital in Toronto, Canada, and Dr. Dennis Shramont of the University of California at Los Angeles jointly announced that a compound that effectively inhibits human breast, ovarian, colon, A new type of targeted drug with a significant tumor shrinkage has been successfully studied in eight kinds of cancers such as bovine myeloma, lung cancer, melanoma, pancreatic cancer and prostate cancer. According to Canadian television, the name for this cure is CFI-400945, which has been developed for as long as 10 years. Traditional cancer treatment mainly radiotherapy and chemotherapy, direct attack and kill cancer cells, its side effect is to kill healthy cells at the same time, have a negative impact on the patient’s body, and as the chemoradiation effect weakened, the weight of cancer cells